SjHSP60 induces CD4(+) CD25(+) Foxp3(+) Tregs via TLR4-Mal-drived production of TGF-β in macrophages.

SjHSP60 induces CD4(+) CD25(+) Foxp3(+) Tregs via TLR4-Mal-drived production of TGF-β in macrophages.
复制标题

SjHSP60 通过 TLR4-Mal 驱动巨噬细胞中 TGF-β 的产生诱导 CD4( )CD25( )Foxp3( ) Tregs

DOI:
10.1111/imcb.12160
复制
发表时间:
2018-10
影响因子:
4
通讯作者:
Su C
Su C
中科院分区:
医学3区
文献类型:
--
作者:
Zhou S;Qi Q;Wang X;Zhang L;Xu L;Dong L;Zhu J;Li Y;Wang X;Xu Z;Liu F;Hu W;Zhou L;Chen X;Su C

文献摘要

参考文献

被引文献

相似文献

CD 4 + CD 25 + Foxp 3+调节性T细胞(Treg)在限制病毒感染后对宿主器官的免疫病理损伤中起关键作用。转化生长因子-β(TGF-β)是通过诱导关键转录因子Foxp 3将CD 4 + CD 25 − T细胞外周转化为CD 4 + CD 25 + Foxp 3 + T细胞的关键因子。抗原提呈细胞(APC)高表达TGF-β,参与寄生虫抗原诱导的外周血Treg转化。然而,寄生虫抗原在APC中高TGF-β诱导的潜在机制仍有待澄清。本研究证明日本血吸虫应激蛋白热休克蛋白60(SjHSP 60)可促进巨噬细胞(Mφ)产生TGF-β。此外,我们发现SjHSP 60激活TLR 4-Mal(MyD 88衔接子样蛋白)信号传导对于诱导Mφ中TGF-β的表达是必需的,其随后促进Treg诱导。我们的研究结果不仅证明了Mφ产生TGF-β诱导血吸虫病小鼠T淋巴细胞增殖的新机制,而且暗示了靶向寄生虫应激蛋白用于潜在治疗的可能性。
CD4+CD25+Foxp3+ regulatory T cells (Tregs) play a pivotal role in limiting immunopathological damage to host organs after schistosome infection. Transforming growth factor-β (TGF-β) is an essential factor for the periphery conversion of CD4+CD25− T cells into CD4+CD25+Foxp3+ Tregs by inducing the key transcription factor Foxp3. Antigen presenting cells (APCs), which highly express TGF-β, are involved in parasite antigen-induced Treg conversion in peripheral. However, the mechanisms underlying high TGF-β induction in APCs by parasite antigens remain to be clarified during schistosome infection. Here, we demonstrated that Schistosoma japonicum stress protein, heat shock protein 60 (SjHSP60), promoted TGF-β production in macrophages (Mφ). Furthermore, we showed that activation of TLR4-Mal (MyD88 adaptor-like protein) signaling by SjHSP60 is necessary for induction of TGF-β expression in Mφ, which subsequently promoted Treg induction. Our results not only demonstrate a novel mechanism of TGF-β production in Mφ for inducing Tregs in mice with schistosomiasis, but also allude to the possibility of targeting parasite stress protein for potential therapeutics.
DOI: 10.1016/j.cell.2006.07.035
发表时间: 2006-09-22
期刊: CELL
影响因子: 64.5
作者:
Ivanov, Ivaylo I.;McKenzie, Brent S.;Littman, Dan R.
通讯作者: Littman, Dan R.
DOI: 10.3389/fimmu.2013.00089
发表时间: 2013
影响因子: 7.3
作者:
Hams E;Aviello G;Fallon PG
通讯作者: Fallon PG
DOI: 10.1002/eji.201344341
发表时间: 2014-07-01
影响因子: 5.4
作者:
Liu, Bi-Sheng;Cao, Yonghao;Toes, Rene E. M.
通讯作者: Toes, Rene E. M.
DOI: 10.1002/eji.201142322
发表时间: 2012-07-01
影响因子: 5.4
作者:
Lee, Kyoo-A;Song, You Chan;Kang, Chang-Yuil
通讯作者: Kang, Chang-Yuil
DOI: 10.1084/jem.20091903
发表时间: 2009-09-28
期刊: The Journal of experimental medicine
影响因子: --
作者:
Maizels RM;Pearce EJ;Artis D;Yazdanbakhsh M;Wynn TA
通讯作者: Wynn TA